MAPK3 and breast cancer: Overexpressing the ER-mediated miR-200b resulted in reduced expression and activity of MMP2, 9, 7 and 14 and ERK1/2 phosphorylation, while having no significant effects in ERα-positive MCF7 breast cancer cells [98].